FORM 4
[ X ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2008
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

PERKINS RICHARD W 		2. Issuer Name and Ticker or Trading Symbol

LIFECORE BIOMEDICAL INC [ LCBM ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

1699 NORTH FARM ROAD 		3. Date of Earliest Transaction (MM/DD/YYYY)

3/20/2008
(Street)

LONG LAKE, MN 55356
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   3/20/2008     U    7500   D $17.00   0   I   see footnotes  
Common Stock   3/20/2008     U    6000   D $17.00   0   I   see footnotes  
Common Stock   3/20/2008     U    10000   D $17.00   0   I   see footnotes  
Common Stock   3/20/2008     U    139000   D $17.00   0   I   see footnote  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy)   $10.78                     (1) 11/11/2014   Common Stock   10000     10000   D    
Stock Option (Right to Buy)   $12.46                     (2) 11/14/2017   Common Stock   7500     17500   D    

Explanation of Responses:
( 1)  100% exercisable.
( 2)  In connection with the February 21, 2008 commencement of the tender offer to purchase all the outstanding common stock of Lifecore at $17.00 per share, all of the outstanding stock options became fully vested and exercisable in their entirety on that date.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
PERKINS RICHARD W
1699 NORTH FARM ROAD
LONG LAKE, MN 55356 		X



Signatures
/s/ Richard W. Perkins 3/24/2008
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Lifecore Biomedical (MM) (NASDAQ:LCBM)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Lifecore Biomedical (MM) Charts.
Lifecore Biomedical (MM) (NASDAQ:LCBM)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Lifecore Biomedical (MM) Charts.